Clinical Trials Logo
  1. Home
  2. Vasospasm
  3. NCT02071875

Comparing the Nautilus NeuroWaveTM to TCD or DSA for the Detection of Vasospasm

Vasospasm Clinical Trial

Official title:
A Non-Randomized, Non-Significant Risk Study Comparing the Nautilus NeuroWaveTM System to Transcranial Doppler or DSA as an Aid to Diagnosing Vasospasm

Clinical Trial Summary

To determine the efficacy of using the Jan Medical NNW system as a diagnostic aid in detection of moderate and severe vasospasm for detection of vasospasm in patients with subarachnoid hemorrhage.

Clinical Trial Description

This study is a prospective, comparative, non-randomized study in subjects with subarachnoid hemorrhage who are undergoing surveillance for vasospasm. The study will be conducted in one center. The primary objective of Phase I of this non-significant risk study is proof of principle. During this phase the goal is to build a library of Jan Medical NNW system recordings from patients with moderate and severe vasospasms. A signature for detecting vasospasms will be developed using the signals from a vasospasm epoch to a patient's individual baseline recording and confirming the presence of vasospasm by comparison of Jan Medical NNW system data to TCD and, when available Digital Subtraction Angiography (DSA). The number of patients required for Phase I is estimated to be 20 patients with confirmed moderate or severe vasospasm with a minimum of 10 these patients having at least one severe vasospasm recording confirmed by TCD or DSA. Daily recordings are to be taken. During Phase II the Jan Medical NNW system will independently utilize the signatures identified in Phase I to identify the presence or absence of moderate and severe vasospasm in a blinded recording. This recording will be compared to TCD or DSA, when DSA is available, for analysis of sensitivity and specificity. Up to 50 subjects will be enrolled in Phase II. When possible, multiple recordings will be obtained from each subject to include recordings with and without vasospasm. Duration of each subject's enrollment in this study is limited to the period of time when Jan Medical NNW system recordings are performed. No additional tests or procedures will be performed during participation in this study and all other data collected (including TCD or DSA) will be based on available evaluations conducted as part of the patient's standard of care. Upon completing the last Jan Medical NNW system recording or when no further data collection is expected, the subject will be exited from the study. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02071875
Study type Observational
Source Jan Medical, Inc.
Contact
Status Terminated
Phase
Start date November 2013
Completion date December 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT06073145 - Transcranial Doppler Using Wearable Ultrasound Patch
Withdrawn NCT02165644 - Carbonic Anhydrase Antagonism in Subarachnoid Hemorrhage Phase 2
Active, not recruiting NCT01752946 - A Registry Study of Shuxuening Injection Used in Hospitals in China N/A
Completed NCT00282893 - Balloon Prophylaxis of Aneurysmal Vasospasm Phase 2
Completed NCT02351518 - Cerebral Autoregulation and Vasospasm in Patients With TBI
Completed NCT00968227 - Effect of Red Blood Cell Transfusion on Brain Metabolism in Patients With Subarachnoid Hemorrhage Phase 1/Phase 2
Recruiting NCT05628948 - Vascular Lab Resource (VLR) Biorepository
Recruiting NCT06329635 - Treatment of Vasospasm of Aneurysmal Subarachnoid Hemorrhage With Intrathecal Nicardipine - FAST-IT Trial N/A
Completed NCT04988932 - Inhaled Nitric Oxide Treatment for Aneurysmal SAH Patients With Intractable Cerebral Vasospasm N/A
Terminated NCT02222727 - Effects of Donepezil on Regional Cerebral Blood Flow Following Aneurysmal Subarachnoid Haemorrhage Phase 2
Completed NCT01779713 - Transcriptomic Signature of Vasospasm Consecutive to Sub-arachnoid Aneurismal Hemorrhage
Active, not recruiting NCT04998370 - Cerebrospinal Fluid Hemoglobin to Monitor for Aneurysmal Subarachnoid Hemorrhage Related Secondary Brain Injury
Recruiting NCT04362527 - Milrinone Infusion for VAsospam Treatment in Subarachnoid hemoRrhage Phase 3
Terminated NCT00930072 - Safety Study of Cervical Sympathetic Block for Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage Phase 2
Completed NCT03894904 - Papaverine vs Heparin for Peripheral Arterial Catheter Patency in Pediatric Patients Phase 4
Withdrawn NCT02093182 - An Innovative Non-invasive Acoustic Approach to Detect and Monitor Cerebral Vasospasm N/A